{"id":"NCT01945034","sponsor":"Pfizer","briefTitle":"5% Topical Ibuprofen (IBU) for Ankle Sprain","officialTitle":"Placebo-controlled, Double-blind Evaluation Of The Efficacy And Safety Of Ibuprofen 5% Topical Gel For The Treatment Of Ankle Sprain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2015-02","completion":"2015-02","firstPosted":"2013-09-18","resultsPosted":"2016-05-26","lastUpdate":"2016-05-26"},"enrollment":304,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Ankle Injuries"],"interventions":[{"type":"DRUG","name":"Topical IBU twice daily","otherNames":[]},{"type":"DRUG","name":"Placebo twice daily","otherNames":[]},{"type":"DRUG","name":"Topical IBU three times daily","otherNames":[]},{"type":"DRUG","name":"Placebo three times daily","otherNames":[]}],"arms":[{"label":"Topical IBU twice daily","type":"EXPERIMENTAL"},{"label":"Placebo twice daily","type":"PLACEBO_COMPARATOR"},{"label":"Topical IBU three times daily","type":"EXPERIMENTAL"},{"label":"Placebo three times daily","type":"PLACEBO_COMPARATOR"}],"summary":"This study is being conducted to evaluate the effects of IBU 5% Topical Gel versus topical placebo for the relief of pain associated with a first or second degree ankle sprain. Both twice daily and three times daily regimens will be evaluated.","primaryOutcome":{"measure":"Sum of Pain Intensity Difference (SPID) on Weight Bearing Over 3 Days (SPID WB0-3)","timeFrame":"Over 3 Days (0-72 hours)","effectByArm":[{"arm":"Ibuprofen Twice Daily","deltaMin":188.9,"sd":14.81},{"arm":"Ibuprofen Thrice Daily","deltaMin":173.6,"sd":13.6},{"arm":"Placebo Combined","deltaMin":165.9,"sd":10.34}],"pValues":[{"comp":"OG000 vs OG002","p":"0.190"},{"comp":"OG001 vs OG002","p":"0.633"},{"comp":"OG000 vs OG001","p":"0.436"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":19,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B3491009&StudyName=5%25%20Topical%20Ibuprofen%20%28IBU%29%20for%20Ankle%20Sprain"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":67},"commonTop":["Headache","Dry skin","Oedema peripheral","Eye irritation","Constipation"]}}